| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 03/03/2004 | EP1392644A1 Cinnamide derivatives as kcnq potassium channel modulators |
| 03/03/2004 | EP1392641A1 Substituted cyclohexane-1,4-diamine derivatives |
| 03/03/2004 | EP1392637A2 Modulators of peroxisome proliferator activated receptors |
| 03/03/2004 | EP1392351A2 Chemokines as adjuvants of immune response |
| 03/03/2004 | EP1392330A1 Use of lps for treating intestinal inflammation processes |
| 03/03/2004 | EP1392329A1 Use of sulodexide for the treatment of inflammatory bowel disease |
| 03/03/2004 | EP1392327A2 Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases |
| 03/03/2004 | EP1392326A1 Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators |
| 03/03/2004 | EP1392321A1 Method of treating inflammatory disorders of the gastrointestinal tract using topical active corticosteroids |
| 03/03/2004 | EP1392318A1 Composition for treating drug-induced constipation with 15-keto-prostaglandins |
| 03/03/2004 | EP1392311A1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 03/03/2004 | EP1392309A1 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 03/03/2004 | EP1392307A1 Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene |
| 03/03/2004 | EP1392306A1 Substituted tetrahydroisoquinolines for use in the treatment of inflammatory diseases |
| 03/03/2004 | EP1392302A1 5-substituted-2-arylpyridines as crf1 modulators |
| 03/03/2004 | EP1392300A1 2,5-disubstituted pyridine, pyrimidine, pyridazine and 1, 2, 4-triazine derivatives for use as p38 inhibitors |
| 03/03/2004 | EP1392298A2 Fused heterocyclic compounds |
| 03/03/2004 | EP1392297A1 Pharmaceutical composition comprising a tricyclic compound for the prevention or treatment of skin diseases |
| 03/03/2004 | EP1392291A2 Tripeptidyl peptidase inhibitors |
| 03/03/2004 | EP1392289A2 Caspase inhibitors and uses thereof |
| 03/03/2004 | EP1392280A2 Arylsulfonamide ethers, and methods of use thereof |
| 03/03/2004 | EP1392276A1 Potentiation of therapeutic effects of polyunsaturated fatty acids |
| 03/03/2004 | EP1392265A2 Inhibitors of abc drug transporters at the blood-brain barrier |
| 03/03/2004 | EP1392252A2 Pharmaceutical composition containing stool softener such as polaxamer and enteric coated particles of bisacodyl |
| 03/03/2004 | EP1392230A1 Methods for treating or preventing diseases of the oral cavity |
| 03/03/2004 | EP1392133A2 Functional agent for decomposing nicotine and method of preparing the same |
| 03/03/2004 | EP1284974B1 Triazolyl tropane derivatives as ccr5 modulators |
| 03/03/2004 | EP1282624B1 Crf receptor antagonists and methods relating thereto |
| 03/03/2004 | EP1259128A4 Water containing soluble fiber |
| 03/03/2004 | EP1196440B1 Therapeutic peptides derived from subsequences of bpi |
| 03/03/2004 | EP1124797B1 N-arylsulfonyl amino acid omega amides |
| 03/03/2004 | EP1047437A4 Sea cucumber carotenoid lipid fraction products and methods of use |
| 03/03/2004 | EP1045839B1 Novel amines as pharmaceutical agents |
| 03/03/2004 | EP0998484B1 Method of identifying compounds having reduced systemic effects |
| 03/03/2004 | EP0998460B1 Novel tetrazole derivatives |
| 03/03/2004 | EP0986386B1 Use of nitrogen heterocyclic aromatic derivatives in the topical treatment of the epithelial tissues diseases |
| 03/03/2004 | EP0874558B8 Liquid oral compositions comprising a calcium compound and an acidulant |
| 03/03/2004 | EP0865290B1 Pharmaceutical compositions for oral use including an nsaid and ceramides |
| 03/03/2004 | EP0738268B1 Trisubstituted phenyl derivatives, processes for their preparation and their use as phosphodiesterase (type iv) inhibitors |
| 03/03/2004 | EP0733103B1 Generation of high titers of recombinant aav vectors |
| 03/03/2004 | EP0613375B1 Pharmaceutical lysine-containing polypeptide compositions and the use thereof |
| 03/03/2004 | CN1479740A Substituted 3,4-dihydro-pyrido [1,2-a] pyrimidines |
| 03/03/2004 | CN1479739A Heterocyclic ether substituted imidazoquinolie compounds |
| 03/03/2004 | CN1479738A Thioether subsituted imidazoquinoline compound |
| 03/03/2004 | CN1479727A Piperazinylpyrazine compounds as agonist or antagonist of 5-hydroxytryptamine 5HT-2 receptor |
| 03/03/2004 | CN1479721A Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
| 03/03/2004 | CN1479716A Propionic acid derivatives with PPAR-alpha activating properties |
| 03/03/2004 | CN1479715A Amide for inhibition of IL-8-induced chemiotaxis of neutrophil leucocytes |
| 03/03/2004 | CN1479712A Ketone compounds and compositions for cholesterol management and related uses |
| 03/03/2004 | CN1479629A Combinations and compositions which interfere with VEGF/VEFG and anglopoietin/Tie receptor function and their use (II) |
| 03/03/2004 | CN1479624A Process for preparing aqueous extracts of plants and extracts so obtained |
| 03/03/2004 | CN1479613A Rapidly disintegrating tablet comprising acid-sensitive active ingredient |
| 03/03/2004 | CN1479611A Pharmaceutical paste comprising acid-labile activeingredient |
| 03/03/2004 | CN1479607A Zinc containing dentifrice of reduced astrigency |
| 03/03/2004 | CN1478783A Inositol polyphosphate ester derivative and its using method |
| 03/03/2004 | CN1478548A compound pepsin powder for treating child dyspepsia and its preparation method |
| 03/03/2004 | CN1478540A Medicinal composition for treating diabetes and its complication and viral hepatitis and its preparation method |
| 03/03/2004 | CN1478535A Chinese medicinal composition for treating 'epigastalgia' deficiency of yin syndrom and its preparation method |
| 03/03/2004 | CN1478532A Sobering and liver protecting liquid product and its production method |
| 03/03/2004 | CN1478528A Chinese Medicine compound preparation for treating fatty liver and its making method |
| 03/03/2004 | CN1478527A Capsule with pilose deerhorn blood and gingeng and its preparation method |
| 03/03/2004 | CN1478520A Heat-clearing and detoxic medicine and its preparation method |
| 03/03/2004 | CN1478519A Application of wintersweet oil in preparation of medicine for treating digestive system discase |
| 03/03/2004 | CN1478516A Subspinose Chinese medicine preparation |
| 03/03/2004 | CN1478515A Desmodium preparation for treating urinary calculus, infection and cholelithiasis cholecy stolithiasis and chole cystitis and its production method |
| 03/03/2004 | CN1478508A Chinese medicinal composition for treating fatty liver and its preparation method |
| 03/03/2004 | CN1478497A Medicine for treating fatty liver |
| 03/03/2004 | CN1478490A Medicinal liquid for treating skin ulceration and stonatocace and its processing technology |
| 03/03/2004 | CN1478474A Milk thistle silybum marianum self-emulsified micro-emulsion composition and its preparation process |
| 03/03/2004 | CN1478465A Biphenyl diester liquid medicinal composition containing fat |
| 03/03/2004 | CN1140526C 8-azabicyclo[3,2,1] octane-3-methanamine derivatives as ligands of D2 and D3 doppamine and 5HT1A and 5HT2 serotonin receptors |
| 03/03/2004 | CN1140525C 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives |
| 03/03/2004 | CN1140509C Novel vitamin D. analogues |
| 03/03/2004 | CN1140508C Substed 4-biphenyl-4-hydroxybutyric acid derivs, and matrix metalloprotease inhibitors |
| 03/03/2004 | CN1140291C Stone-eliminatnig Jinyi medicine powder |
| 03/03/2004 | CN1140287C Oral medicine for treating spleen and stomach alisease |
| 03/03/2004 | CN1140275C Oral powder for treating mouth disease |
| 03/03/2004 | CN1140271C Medicine for treating vertigo |
| 03/03/2004 | CN1140269C Bicyclic compounds capable of inhibiting tyrosine kinases of epidermal growth factor receptor family |
| 03/03/2004 | CN1140264C Chewing gum containing colloidal bismuth subcitrate |
| 03/03/2004 | CN1140182C Coca components, edible products having enhanced polyphenol content, methods of making same and medical us |
| 03/02/2004 | US6699910 Ketone compounds and compositions for cholesterol management and related uses |
| 03/02/2004 | US6699903 Hydration of the anhydrous lithium salt with acetonitrile and water; phosphodiesterase inhibitors |
| 03/02/2004 | US6699899 Substituted acylhydroxamic acids and method of reducing TNFα levels |
| 03/02/2004 | US6699888 Antiinflammatory |
| 03/02/2004 | US6699885 Substituted benzimidazole dosage forms and methods of using same |
| 03/02/2004 | US6699880 Substituted imidazolidinone derivatives |
| 03/02/2004 | US6699877 Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives |
| 03/02/2004 | US6699871 Such as 7-((3r)-3-amino-4-(3,4-difluorophenyl)butanoyl)-2-(trifluoromethyl)-5,6,7,8 -tetrahydroimidazo(1,2-a)pyrazine dihydrochloride for treatment of insulin resistance disorders |
| 03/02/2004 | US6699867 4-(4-Methyl-piperazin-1-ylmethyl)-4,5-dihydrothiazol-2-ylamine |
| 03/02/2004 | US6699865 Protein kinase inhibitors, for treating cancer inflammatory disorders, restenosis, and cardiovascular disease. |
| 03/02/2004 | US6699860 Di-substituted aminomethyl-chroman derivative beta-3 adrenoreceptor agonists |
| 03/02/2004 | US6699855 Pyrrolopyrazinones useful as serine protease inhibitors |
| 03/02/2004 | US6699852 Substituted pyridoindoles as serotonin agonists and antagonists |
| 03/02/2004 | US6699840 Controlled- or delayed-release forms of topiramate |
| 03/02/2004 | US6699716 In vivo induction for enhanced function of isolated hepatocytes |
| 03/02/2004 | US6699466 IL-16 antagonist peptides and DNA encoding the peptides |
| 03/02/2004 | CA2259449C Treatment of sepsis-induced acute renal failure and renal vasoconstriction and catecholamine-induced renal and mesenteric vasoconstriction |
| 03/02/2004 | CA2149441C Activin receptor-like kinases, proteins having serine threonine kinase domains and their use |
| 02/26/2004 | WO2004016617A1 Biaryl diazabicycloalkane amides as nicotinic acetylcholine agonists |